🟠 Moderate Evidence
Most consumers assume that vitamin D supplements work the same way across different doses and that “more is better.” Neither assumption is accurate. Research published in the American Journal of Clinical Nutrition shows that the relationship between vitamin D intake and blood levels follows a curvilinear—not linear—curve, and crucially, your starting blood level determines how much each additional dose will raise your serum concentration.
Key takeaways
- A tenfold increase in vitamin D dose does not produce a tenfold increase in serum levels; it produces only approximately 2.8 times the level
- The same 1,000 IU supplement raises serum 25-hydroxyvitamin D by approximately 11 ng/mL if your baseline is deficient (10 ng/mL) but only 5 ng/mL if your baseline is already 50 ng/mL
- Vitamin D is actively regulated by the body through hepatic hydroxylation, binding protein saturation, and catabolic clearance—not passively accumulated
Study at a Glance
| Source | American Journal of Clinical Nutrition |
| Study type | Controlled intervention study |
| Sample size | Healthy men during winter in Nebraska (dose-response phase) |
| Population | Healthy adult males |
| Country | United States |
Vitamin D Dose Does Not Scale Linearly with Serum Levels
Serum 25-hydroxyvitamin D achieved at steady state by daily supplementation dose, United States, 2003
Source: Heaney et al., American Journal of Clinical Nutrition, 2003 | Georgian Medical Journal News
The physiology of vitamin D regulation
In a controlled study published in the American Journal of Clinical Nutrition, researchers led by Robert Heaney gave healthy men three different daily doses of cholecalciferol (vitamin D3): approximately 1,000 IU, 5,500 IU, and 11,000 IU during winter months in Nebraska. The researchers then measured serum 25-hydroxyvitamin D (the standard biomarker for vitamin D status) until steady state was reached.
The results demonstrated a striking nonlinear relationship. The 1,000 IU dose achieved approximately 30 ng/mL; the 5,500 IU dose reached about 60 ng/mL; and the 11,000 IU dose resulted in roughly 84 ng/mL. Tenfold the dose produced only 2.8 times the circulating vitamin D level. This plateau occurs because the body does not passively accumulate vitamin D. Instead, homeostatic mechanisms actively regulate its circulation: the liver increases hydroxylation rates at higher levels, binding proteins become saturated, and the body accelerates catabolic clearance.
Roughly ten times the dose did not produce ten times the serum level. It produced about 2.8 times the level, because the body actively regulates vitamin D circulation through hepatic hydroxylation, binding protein saturation, and catabolic clearance.
— Robert Heaney, Creighton University (American Journal of Clinical Nutrition, 2003)
Starting level determines individual response
The dose-response curve flattens further when accounting for an individual’s baseline vitamin D status. In a follow-up community-based cohort study of 3,667 adults published in Anticancer Research, Heaney’s team calculated the first derivative of the dose-response relationship at different starting levels, quantifying how much each additional 1,000 IU raises serum 25(OH)D depending on baseline status.
The magnitude of effect varied dramatically. At a baseline of 10 ng/mL (deficient), each additional 1,000 IU/day raised serum 25(OH)D by approximately 11 ng/mL. However, at a baseline of 30 ng/mL (insufficient), the same 1,000 IU produced only an 8 ng/mL increase. At 50 ng/mL, the increment dropped to approximately 5 ng/mL. Above 70 ng/mL, the response flattened to near-zero. This means the identical pill produces dramatically different results depending on where a person’s serum level starts—a phenomenon that shelves of standard-dose supplements cannot account for.
Clinical implications for supplementation strategies
These findings suggest that the common practice of selecting a vitamin D supplement based solely on shelf availability or package marketing is physiologically misaligned. A person with severe deficiency (10 ng/mL) who takes a standard 1,000 IU supplement daily might reach only about 21 ng/mL after months, while a person starting at 50 ng/mL taking the same dose may see minimal further change. This underscores the importance of baseline serum testing before supplementation and dose titration based on individual response rather than a one-size-fits-all approach.
The research, grounded in the evidence-based practice framework for personalized medicine, suggests that clinicians and public health practitioners should move beyond fixed supplementation protocols and instead tailor recommendations to measured baseline levels and target endpoints. For consumers, this highlights why working with a healthcare provider to establish a baseline serum 25(OH)D level—rather than self-selecting a bottle from the shelf—yields more predictable and effective supplementation outcomes. The dose-response relationship for vitamin D is not a simple linear math problem; it is a regulated physiological system responsive to individual starting conditions.
What this means
Frequently asked questions
Why doesn’t doubling my vitamin D dose double my serum level?
Vitamin D is not passively accumulated. Once absorbed, it is hydroxylated in the liver and bound to proteins in the blood. As serum 25(OH)D rises, the body increases the rate at which it breaks down and clears vitamin D (catabolic clearance) and saturates its binding proteins. This active homeostatic regulation prevents excessive accumulation, similar to how the body regulates calcium. According to Heaney et al. (2003), this regulatory mechanism means each incremental dose produces progressively smaller increases in serum levels.
Should I take a high-dose vitamin D supplement if I’m deficient?
A high-dose supplement may be appropriate for severe deficiency, but response depends on your baseline level. At very low baseline (10 ng/mL), a 1,000 IU supplement raises your level by roughly 11 ng/mL; but taking 10,000 IU will not raise it by 110 ng/mL due to the curvilinear dose-response. Work with your clinician to establish a baseline, agree on a target level, and retest after 8–12 weeks. Clinical guidance increasingly favours this personalised approach over standard protocols.
What serum vitamin D level should I aim for?
There is no universal consensus, but most clinical groups recommend a minimum of 30 ng/mL for bone and immune health, with some suggesting 40–50 ng/mL as optimal. Levels above 100 ng/mL are not known to offer additional benefit and may increase certain risks. Your target should be individualised based on age, health status, and risk factors. Your clinician can recommend a target based on current evidence and your personal health profile.
The vitamin D story exemplifies a broader principle in personalized medicine: physiology is not standardized, and neither should supplementation be. As testing becomes more accessible and cost-effective, baseline measurement and dose titration offer a more rational alternative to shelf-based guessing. The next time you reach for a vitamin D bottle, consider reaching for a blood test first.
Source: Heaney et al., American Journal of Clinical Nutrition, 2003; Heaney et al., Anticancer Research, 2011
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
